About Index Trending news
Analyze
Pricing
Nektar Therapeutics

Nektar Therapeutics

Work at Nektar Therapeutics? Add yourself to this profile

Nektar Therapeutics

Nektar is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates designed to improve the benefits of drugs for patients.

Elsewhere

Alexa global traffic share

Twitter followers

01 Jun 2016
$20,000,000
Post-IPO equity
Added by

Nektar Therapeutics Gets $20M in Daiichi Deal For Breast Cancer Drug

Xconomy
28 Aug 2013
$25,000,000
Venture capital